$382 Million is the total value of Essex Woodlands Management, Inc.'s 9 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ABMD | Sell | ABIOMED INC | $137,475,000 | -29.2% | 1,450,000 | -32.6% | 35.98% | +1.4% |
RVNC | REVANCE THERAPEUTICS INC | $80,177,000 | -48.9% | 4,592,047 | 0.0% | 20.98% | -26.9% | |
ENTL | ENTELLUS MED INC | $69,362,000 | +7.9% | 3,813,197 | 0.0% | 18.15% | +54.4% | |
CORI | CORIUM INTL INC | $36,104,000 | -52.5% | 9,353,304 | 0.0% | 9.45% | -32.0% | |
AXGN | AXOGEN INC | $26,056,000 | +7.2% | 4,861,111 | 0.0% | 6.82% | +53.4% | |
ELGX | ENDOLOGIX INC | $16,776,000 | -9.2% | 1,257,468 | 0.0% | 4.39% | +29.9% | |
MNOV | MEDICINOVA INC | $8,591,000 | +106.8% | 1,170,370 | 0.0% | 2.25% | +195.8% | |
ACUR | ACURA PHARMACEUTICALS INC | $5,537,000 | +13.2% | 1,956,397 | 0.0% | 1.45% | +62.1% | |
CBIO | CATALYST BIOSCIENCES INC | $2,017,000 | -46.6% | 1,179,352 | 0.0% | 0.53% | -23.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MEDICINOVA INC | 42 | Q3 2023 | 6.5% |
REVANCE THERAPEUTICS INC | 39 | Q3 2023 | 44.6% |
AXOGEN INC | 26 | Q4 2021 | 43.3% |
ENDOLOGIX INC | 24 | Q1 2019 | 22.5% |
ABIOMED INC | 20 | Q1 2018 | 52.1% |
CORIUM INTL INC | 20 | Q1 2019 | 23.5% |
TELA BIO, INC. | 16 | Q3 2023 | 31.5% |
VENUS CONCEPT, INC. | 16 | Q3 2023 | 21.3% |
ACURA PHARMACEUTICALS INC | 15 | Q1 2019 | 1.4% |
CATALYST BIOSCIENCES INC | 15 | Q1 2019 | 1.0% |
View Essex Woodlands Management, Inc.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
View Essex Woodlands Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.